Pharmacopoeia, Stability & Safety

Fujicalin® is manufactured under strict quality control at our FDA-GMP certified facilities. Fujicalin® meets all the requirements of the current USP/NF, EP and JP. A US DMF type IV filed in 1998.

Dosage and Safety

Fujicalin® (Dibasic calcium phosphate anhydrous) is widely used in oral pharmaceutical products and food products. It is generally regarded as relatively nontoxic and nonirritant material. It is listed as GRAS material.

Stability

Fujicalin® is a stable inorganic compound and meets EP, USP/NF and JPC specifications. It is stable for 3 years from the date of manufacture.